Three-dimensional MR pulmonary perfusion imaging and angiography with an injection of a new blood pool contrast agent B-22956/1

J Magn Reson Imaging. 2001 Oct;14(4):425-32. doi: 10.1002/jmri.1203.

Abstract

Initial evaluation of a new blood pool agent, B-22956/1, for pulmonary imaging was performed in five domestic pigs with artificial embolism. Pre-embolism 3D pulmonary perfusion images were first acquired by injecting an extravascular agent, gadoteridol. The pulmonary arteries of the pigs were then occluded by the artificial emboli. Post-embolism perfusion scans were subsequently performed by injecting B-22956/1. Additional post-embolism high-spatial-resolution angiograms were also acquired. Parenchyma perfusion deficits were well depicted in the post-embolism perfusion maps. The post-embolism angiography clearly revealed the location and extent of the filling defects in the pulmonary vessels. Signal intensities of perfusion maps on the normal parenchyma were significantly improved (30%) by using B-22956/1, in comparison with perfusion images using gadoteridol (P < 0.01). Many pulmonary angiograms with approximately equal contrast could be obtained even at 22 minutes after the injection of B-22956/1. Our initial results indicate that blood pool agent B-22956/1 may provide opportunities for whole-lung-coverage perfusion mapping and additional high-resolution target angiograms after a single injection.

Publication types

  • Comparative Study
  • Evaluation Study

MeSH terms

  • Animals
  • Contrast Media*
  • Gadolinium
  • Heterocyclic Compounds
  • Lung / anatomy & histology*
  • Lung / physiology
  • Magnetic Resonance Angiography / methods*
  • Magnetic Resonance Imaging / methods*
  • Organometallic Compounds*
  • Pulmonary Circulation / physiology*
  • Pulmonary Embolism / diagnosis
  • Swine

Substances

  • B-22956-1
  • Contrast Media
  • Heterocyclic Compounds
  • Organometallic Compounds
  • gadoteridol
  • Gadolinium